Objective-Transcription factor GATA (GATA zinc finger transcription factor family)-6 is highly expressed in vessels and rapidly downregulated in balloon-injured carotid arteries and viral delivery of GATA-6 to the vessels limited the neointimal formation, however, little is known about its cell-specific regulation of in vivo vascular smooth muscle cell (VSMC) phenotypic state contributing to neointimal formation. This study aims to determine the role of vascular cellspecific GATA-6 in ligation-or injury-induced neointimal hyperplasia in vivo. Approach and Results-Endothelial cell and VSMC-specific GATA-6 deletion mice are generated, and the results indicate that endothelial cell-specific GATA-6 deletion mice exhibit significant decrease of VSMC proliferation and attenuation of neointimal formation after artery ligation and injury compared with the wild-type littermate control mice. PDGF (plateletderived growth factor)-B is identified as a direct target gene, and endothelial cell-GATA-6-PDGF-B pathway regulates VSMC proliferation and migration in a paracrine manner which controls the neointimal formation. In contrast, VSMCspecific GATA-6 deletion promotes injury-induced VSMC transformation from contractile to proliferative synthetic phenotype leading to increased neointimal formation. CCN (cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed family)-5 is identified as a novel target gene, and VSMC-specific CCN-5 overexpression in mice reverses the VSMC-GATA-6 deletion-mediated increased cell proliferation and migration and finally attenuates the neointimal formation. Conclusions-This study gives us a direct in vivo evidence of GATA-6 cell lineage-specific regulation of PDGF-B and CCN-5 on VSMC phenotypic state, proliferation and migration contributing to neointimal formation, which advances our understanding of in vivo neointimal hyperplasia, meanwhile also provides opportunities for future therapeutic interventions. Visual Overview-An online visual overview is available for this article. Zhuang et al
P ercutaneous coronary intervention (PCI) is a well-established treatment for coronary artery disease but has long been compromised by the major limitation of restenosis after PCI. The key pathophysiologic mechanisms of restenosis after vascular injury is neointimal formation, which essentially occurs because of alteration of a quiescent differentiated medial vascular smooth muscle cell (VSMC) contractile phenotype to the proliferative synthetic state with subsequent migration to the intima. [1] [2] [3] Given the importance of VSMC proliferation and migration in the intimal thickening response after vascular injury, a more thorough understanding of the cell lineage-specific pathways that regulate this process is warranted.
GATA (GATA zinc finger transcription factor family) factors are highly conserved transcription factors with 2 tandem zinc fingers that interact with other transcriptional regulators and bind the canonical DNA motif, (G/A)GATA(A/T). They have been implicated in various developmental processes, including cell proliferation and differentiation. [4] [5] [6] GATA-6 is a highly expressed GATA factor in the vessel wall. 7, 8 The high GATA-6 expression in quiescent vasculature is rapidly downregulated in injured vasculature in vivo 9 and in proliferating VSMCs in vitro. 7 Overexpression of GATA-6 in cultured proliferating VSMCs produces cell cycle arrest. 10 Furthermore, adenovirus-mediated GATA-6 gene transfer to the vessel wall after balloon injury partially restored GATA-6 levels and rescued injury-induced VSMC phenotypic modulation and reduced the neointimal hyperplasia in the rat. 9 However, the direct in vivo evidence of vascular cell-specific effects of GATA-6 on neointimal formation is still lacking and its molecular mechanism is far from clear. More detailed investigations are warranted to confirm the role of SMC GATA-6 on neointimal formation and to clarify its underlying mechanism.
GATA-6 is highly expressed in human primary endothelial cells (ECs) as well as in murine ECs. 11 The vascular monolayer ECs produce many vasoactive molecules to maintain vascular homeostasis and modulate vasomotor tone. PCI-induced vascular injury results in a complex cascade of events involving release of growth factors, cytokines, and platelet activation. 12 The release of cytokines and growth factors by activated endothelium stimulates the proliferation and migration of SMCs, and thereby promotes the formation of neointima and occurrence of restenosis. 13 Endothelial denudation results in neointimal thickening, and the degree of endothelial injury by stent deployment is an important determinant in intimal thickening to vascular injury. [14] [15] [16] A previous study showed that activation of ECs was associated with GATA-6 nuclear translocation, chromatin binding, and enhanced GATA-6-dependent transcriptional activation of VCAM (vascular cell adhesion molecule)-1. 17 Also endothelial GATA-6 deficiency was reported to be critical in the development and progression of pulmonary arterial hypertension. 18 Given the importance of activated ECs in stimulating the proliferation, migration, and function of VSMCs, we hypothesized that endothelial GATA-6 might be involved in the regulation of neointimal formation.
To address these issues further, we generated vascular ECand SMC-specific GATA-6 deletion mice and investigated the cell-specific effects of GATA-6 on in vivo neointimal formation following artery injury. Loss of GATA-6 specifically in ECs resulted in reduced ligation-and injury-induced neointimal hyperplasia and decreased VSMC proliferation and migration, and we identified PDGF (platelet-derived growth factor) as the direct downstream target gene in ECs. In contrast, loss of GATA-6 specifically in VSMCs resulted in increased VSMC proliferative synthetic phenotype transformation and promoted cell migration to neointima. We showed that CCN (cysteine-rich 61/connective tissue growth factor/nephroblastoma overexpressed family)-5 was a novel direct target gene in VSMCs and loss of VSMC GATA-6 significantly reduced CCN-5 expression. Moreover, VSMC-specific overexpression of CCN-5 or local delivery of lentiviral-CCN-5 rescued the increase of injury-induced VSMC transformation to proliferative synthetic phenotype in the neointima and reduced in vitro cell migration, and finally attenuated the neointimal formation. Taken together, these data indicate that GATA-6 regulates the injury-induced neointimal hyperplasia through cell-autonomous CCN-5 and nonautonomous PDGF-B mechanisms.
Materials and Methods
The authors declare that all supporting data are available within the article (and in the online-only Data Supplement).
Mice
A conditional loss of GATA-6 mouse line 19 
SMCKO
) mice for VSMC-specific deletion of GATA-6. The SM-MHCCre ERT2 transgene is located on the Y chromosome, and thus a single copy of the transgene is maintained for passage through male breeders and these male mice have inducible Cre expression which we used for VSMC-specific GATA-6 deletion studies, whereas both male and female mice were used in EC-specific GATA-6 deletion studies. A CCN-5 gain-of-function mice CCN5 Tg/+ was generated by inserting an CCN5-3Xflag-IRES-EGFP cassette into Rosa26 locus with genotyping using general polymerase chain reaction (PCR) primers for EGFP (enhanced green fluorescent protein). 23 The mice were crossed with smooth muscle myosin heavy chain (Sm-mhc) promoter-driven Cre ERT2 line to obtain VSMC-specific CCN-5 overexpression mice CCN5 
Mouse Neointimal Hyperplasia Model and Quantification of Neointimal Formation
A well-characterized murine femoral artery wire injury model for neointimal hyperplasia was performed as described previously. 24 Briefly, 8-to 10-week-old male GATA6 SMCKO or GATA6 ECKO mutant and wild-type littermate mice were anesthetized with an intraperitoneal injection of 100 mg/kg Ketamine-HCl and 10 mg/kg xylazineHCl, and the femoral artery on the left side was separated and looped proximally and distally with 6-0 silk suture for temporary blood flow cessation. A small branch between the rectus femoris and vastus medialis muscles was isolated, and a transverse arteriotomy was 25 Briefly, the mice were anesthetized and left common carotid artery was completely tied off by suture just proximal to the carotid bifurcation. The mice were euthanized 28-day postsurgery and arteries were harvested, fixed with 4% paraformaldehyde, embedded in paraffin wax, and sectioned at 8 μm intervals for histology analysis. The cross-sections of the injured and sham control arteries were obtained at 200 μm to 2000 μm distant from the ligation at 100 μm intervals, and 8 levels of hematoxylin and eosin staining images were used for quantification of neointima formation per mice.
The images were acquired with Leica DM750 microscope. Measurements were made for lumen circumference, the internal elastic lamina circumference, the circumference of the external elastic lamina. Measurements were quantified using Image Pro software (Media Cybernetics, Bethesda, MD). The neointima area was determined by subtracting the luminal area from the area bound by the internal elastic lamina. The media area was determined by subtracting the area bound by the internal elastic lamina from the area bound by the external elastic lamina. The intima-to-media ratio was determined by intimal area divided by the medial area. Percentage of stenosis was calculated as the ratio of the intimal area to the area inside the original internal elastic lamina. Measurements were performed with the observer blinded to experimental group.
Statistical Analysis
Data were presented as mean±SEM, and the statistical analysis was performed by SPSS 15.0 software package (SPSS Inc, Chicago, IL). All data in the article passed the normality and equal variance, and unpaired 2-tailed Student t test was used for comparisons between 2 groups, and 1-way ANOVA followed by Tukey multiple comparison analysis for multiple groups. P<0.05 was considered statistical significance.
Results

Loss of GATA-6 in ECs Reduces VSMC Proliferation and Migration and Attenuates Neointimal Hyperplasia Induced by Artery Ligation or Wire Injury
Vascular endothelium is a gatekeeper of vessel health and changes in this single cell layer of the artery wall are believed of primary importance in the pathogenesis of vascular diseases including neointimal thickening and atherosclerosis. GATA-6 is highly expressed in human and mouse ECs 11 and EC activation was reported to be associated with enhanced GATA-6-dependent transcriptional activation. 17 Our study confirmed elevated GATA-6 expression in ECs after ligation carotid artery for 3 days (P3) by immunostaining ( Figure I in the online-only Data Supplement).
To investigate the effect of EC-specific GATA-6 on vascular neointimal formation, EC-specific GATA-6 deletion mice GATA6 ECKO were generated, and the efficiency of Cremediated recombination was monitored by immunostaining. Tamoxifen treatment ( Figure 1A ; 100 mg/kg, intraperitoneal every other day for total 4×) resulted in significant reduction of GATA-6 expression in ECs of femoral artery of GATA6 ECKO mutant compared with the littermate wild-type control mice, which was further confirmed in lung and aortic ECs by realtime quantitative reverse transcription (RT-qPCR) and lung ECs by Western blot (Figure 1B) , suggesting the specific loss of GATA-6 in ECs of GATA6 ECKO mutant mice.
The specific loss of GATA-6 in ECs caused a significant decrease of neointimal hyperplasia at 28 days with significant reduction of neointimal area and intima-to-media ratio compared with the littermate wild-type mice in carotid ligation model, and no significance was observed between male and female mice ( Figure 1C ). Immunostaining showed a significant reduction of Ki67-positive cells in the neointima of GATA6 ECKO mice compared with littermate wild-type mice ( Figure 1D) . A recent study used multicolor lineage labeling and demonstrated that the injury-induced neointima was formed mostly by medial VSMCs proliferation. 26 Therefore, these results suggested that the reduction of VSMC proliferation in GATA6 ECKO mutants possibly contributes to the less neointimal formation after carotid artery ligation.
Endothelial integrity is essential for vascular function and endothelial denudation results in neointimal thickening. Femoral artery wire injury is a good EC-denudation-induced neointimal formation model. Fast EC repair was reported after denudation in wire injury of femoral artery. 27, 28 Using whole mount analysis of femoral artery in EC-fluorescent reporter mice (RosaRFP;Cdh5Cre
ERT2
), we confirmed 80% EC coverage in the femoral artery at 7 days following EC denudation ( Figure IIA in the online-only Data Supplement), which was also observed in hematoxylin and eosin staining of femoral artery cross-section and Evans blue in situ staining of femoral artery ( Figure IIB and IIC in the online-only Data Supplement). Neointimal hyperplasia usually occurs most significantly at 28 days after injury, therefore, femoral artery wire injury model could be used to study the GATA-6 effects of reendothelialized ECs on in vivo neointimal formation.
As expected, we observed a significant inhibition of neointimal hyperplasia phenotype at 28 days after wire injury of femoral artery in GATA6 ECKO mutants compared with the wildtype littermates, with a significant reduction of neointimal area, intima-to-media ratio and percentage of stenosis, but no influence on media area ( Figure 1E ), although not as dramatic as that after carotid artery ligation. There was no significance observed between male and female mice. Immunostaining also showed a significant decrease of Ki67-positive cells in the neointima of GATA6 SMCKO mice ( Figure 1F ). These results suggested that GATA-6 deletion of the newly reendothelialized ECs in wire-injured femoral artery of GATA6 ECKO mutants could also influence VSMC proliferation and reduce the neointimal hyperplasia, although not as dramatic as that in carotid ligation model where ECs existed at all time during neointimal formation.
To verify the in vivo findings, we used shRNA to knockdown GATA-6 in cultured ECs and observed the influence of EC condition medium on VSMC proliferation and migration. The efficiency of GATA-6 knockdown by lentiviral-shRNA was confirmed by RT-qPCR and Western blot ( ECKO mutants of both male and female genders exhibit decreased neointimal hyperplasia at 28 d after carotid artery ligation compared with wild-type control littermates, with representative images (left) and quantification of neointima area and intima-to-media ratio (right; n=7 for each group). D, GATA6 ECKO mutants of both genders exhibit significantly reduced Ki67-positive cells in the neointima at 28 d after carotid artery ligation compared with wild-type littermates, with representative images (left) and quantification data (right) (n=7 for each group). E, GATA6 ECKO mutants of both genders exhibit decreased neointimal hyperplasia at 28 d after femoral artery wire injury compared with wild-type littermates, with representative images (top) and quantification of neointima area, intima-to-media ratio, % stenosis and media area (bottom; n=7 for each group). F, GATA6 ECKO mutants of both genders exhibit significantly reduced Ki67-positive cells in the neointima at 28 d after femoral artery wire injury compared with the littermate wild-type mice, with representative images (left) and quantification data (right; n=7 for each group). *P<0.05, **P<0.01. Scale bars: 50 µm (B); 100 µm (C-F). NS indicates nonsignificant.
Both in vivo and in vitro evidence demonstrate EC-GATA-6 nonautonomously regulates VSMC proliferation and migration and controls neointimal formation during injury. Endothelial integrity is important for vascular health and EC denudation resulted in neointimal formation, therefore, we investigated how EC-GATA-6 autonomously regulate EC function contributing to injury-induced neointimal formation. The results showed that GATA6 ECKO mutants exhibited decreased EC recovery at day 5 after femoral artery injury by Evans blue assay ( Figure IVA These results suggest that EC-GATA-6 decreases EC proliferation and migration and reduces EC recovery after wire injury, which might aggravate neointimal formation. However, GATA6
ECKO mutants exhibited attenuation of neointimal formation in both carotid artery ligation and femoral artery wire injury model, supporting that the inhibitory effect of EC-GATA-6-deficiency on neointimal formation via paracrine regulation of VSMC proliferation and migration through PDGF-B praxis overcomes its enhancing effect on neointimal formation via autocrine influence of EC recovery, finally leading to the attenuation of vascular injury-induced neointimal formation.
PDGF-B Is Identified as a Direct Target Gene of GATA-6 in ECs and Regulates VSMC Proliferation and Migration in a Paracrine Manner to Control Neointimal Formation
To gain insight into the underlying molecular mechanisms of EC-GATA-6 deletion-mediated reduction of ligation-or injury-induced neointimal hyperplasia, RNA high-throughput sequencing was performed using ECs from fluorescent reporter mutants mice GATA6 Figure 3A and 3B) .
To validate whether PDGF-B is a direct GATA-6 target gene, we performed chromatin immunoprecipitation assays in mouse lung ECs and found a direct association of GATA-6 with mouse PDGF-B promoter ( Figure 3C ). To determine whether GATA-6 could directly activate PDGF-B transcription, we ECKO mutant mice exhibit reduced expression of PDGF-B, as shown by RT-PCR in lung and aortic ECs (A) and Western blot in lung ECs (B) compared with wild-type littermates (n=3). C, Chromatin immunoprecipitation assay shows an association of GATA-6 with mouse PDGF-B promoter by qPCR (right) and in agarose gel (left; n=3). D, The promoter region of PDGF-B, −2.7 kb to −1.9 kb has 3 GATA-6-binding sites (left) and GATA-6 expression vector transactivates the luciferase reporter activity of this PDGF-B promoter region in NIH-3T3 cells by luciferase assay, and mutation of the GATA-6-binding motif in the promoter region reverses the activated luciferase activity (right; n=3). E and F, Exogenous PDGF-B reverses the reduced neointimal hyperplasia at 28 d after carotid artery ligation (E) or after femoral artery wire injury (F) on loss of EC-GATA-6, with representative images (left) and quantification of neointima area and intima-to-media ratio (right; n=7 for each group). G and H, PDGF-B reverses the reduction of Ki67-positive cells in neointima at 28 d after carotid artery ligation (G), or after femoral artery wire injury (H) on loss of EC-GATA-6, with representative images (left) and quantification data (right; n=7 for each group). *P<0.05, **P<0.01. E-H, Scale bars: 100 µm. KO indicates EC-specific GATA6 deletion mice; and NS, nonsignificant.
luciferase activity (Figure 3D ), thus providing further evidence that PDGF-B is a direct target gene of GATA-6 in ECs.
GATA-6 was reported to regulate EC function via autocrine TGF (transforming growth factor)-β signaling 11 and growth factor or hypoxic conditions elevated PDGF-B expression in ECs, 29 thus we hypothesize the expression level change of GATA-6 and PDGF-B in ECs during vascular injury regulates the neointimal formation. As expected, elevated expression of GATA-6 and PDGF-B was observed at day 3 after carotid artery ligation by immunostaining ( Figure VIA in the online-only Data Supplement), and GATA-6 expression level varied in parallel with PDGF-B in lung and aortic ECs when they upregulated by hypoxia ( Figure VIB in the online-only Data Supplement), whereas EC-GATA-6 deletion mice had reduced PDGF-B expression in lung ECs as well as in aortic ECs which exhibited reduced neointimal formation ( Figure 1B) . These results suggest that EC-GATA-6 might regulate endogenous PDGF-B expression in vivo responsible for neointimal formation during injury.
It was reported that EC-derived PDGF-B was involved in regulation of VSMC proliferation and migration in a paracrine manner to control vascular remodeling induced by low shear stress. 30 To clarify whether EC-GATA-6-PDGF-B pathway regulates VSMC proliferation and migration and contributes to the neointimal formation, we attempted to rescue the EC-GATA-6 deletion-mediated reduced neointimal hyperplasia phenotypes by local application of PDGF-B to the ligation or injury vessel. The results demonstrated that PDGF-B significantly reversed the reduction of neointimal hyperplasia in GATA6 ECKO mutant mice as shown by reversal of the reduced neointimal area, intima-to-media ratio in both carotid artery ligation ( Figure 3E ) and femoral artery wire injury model ( Figure 3F ) compared with the vehicle control. Immunostaining showed that PDGF-B reversed the reduced Ki67-positive cells in the neointima of GATA6 ECKO mutant mice in both models ( Figure 3G and 3H), suggesting that the EC-GATA-6-PDGF-B signal might regulate VSMC proliferation and control in vivo neointimal formation.
To confirm these in vivo findings, a lentiviral PDGF-B overexpression vector was constructed to investigate the role of EC-PDGF-B in VSMC proliferation and migration. The efficiency of elevated PDGF-B expression in human umbilical ECs was confirmed by RT-qPCR and Western blot ( Figure  VII in the online-only Data Supplement). The condition medium from lentiviral PDGF-B-infected human umbilical ECs significantly reversed the EC-GATA-6 knockdown-mediated reduced cell proliferation ( Figure 4A through 4C ) and migration ( Figure 4D and 4E ) of HASMCs compared with that from control lentiviral vector, thus providing evidence that the EC-GATA-6-PDGF-B pathway might regulate VSMC proliferation and migration in a paracrine manner resulting in the attenuation of in vivo neointimal formation.
Loss of GATA-6 in VSMCs Increases the Transformation From Contractile to Proliferative Synthetic Phenotype and Promotes Cell Migration Contributing to the Increased Injury-Induced Neointimal Hyperplasia
GATA-6, besides expression in ECs, is highly expressed in quiescent VSMCs and rapidly decreases in proliferating VSMCs in vitro 7 and in injured vasculature in vivo 9 and elevated GATA-6 expression in injured vessels by local adenovirus-mediated gene transfer inhibited the in vivo neointimal formation. 9, 31 Our results confirmed significant reduction of GATA-6 expression in cultured primary proliferating VSMCs compared with the serum-starved quiescent VSMCs ( Figure  VIIIA and VIIIB in the online-only Data Supplement), as well as in femoral artery medial smooth muscle following wire injury in vivo, compared with that of noninjury artery ( Figure  VIIIC in the online-only Data Supplement), suggesting that GATA-6 regulates VSMC proliferation.
To explore the VSMC-specific role of GATA-6 and its underlying mechanisms in vascular injury-induced neointimal hyperplasia in vivo, we generated VSMC-specific GATA-6 deletion mice GATA6 SMCKO . Tamoxifen treatment (100 mg/ kg, intraperitoneal every other day for total 4×) resulted in significant reduction of GATA-6 expression in VSMCs of the femoral artery by immunostaining, which was confirmed by RT-qPCR and Western blot of media smooth muscle of aortic media smooth muscle ( Figure 5A ), suggesting that GATA-6 is specifically lost in VSMC of GATA6 SMCKO mutant mice.
GATA6
SMCKO mutants exhibited an increase of neointimal hyperplasia at 28 days after wire injury of femoral artery with a significant elevation of neointimal area, intima-to-media ratio and percentage of stenosis compared with the littermate wildtype mice, but no influence on vessel media area ( Figure 5B ; P<0.01). Immunostaining showed a significant reduction of α-SMA (alpha-smooth muscle actin; Figure 5C ) but an increase of Ki67-positive cells ( Figure 5D ) in the neointima of GATA6 SMCKO mice compared with the wild-type littermates, suggesting that VSMC-specific loss of GATA-6 promotes the transformation of VSMC from contractile to synthetic phenotype and increases the cell proliferation contributing to more neointimal hyperplasia after wire injury of femoral artery.
Consistent with these in vivo findings, we found that knockdown of GATA-6 by lentiviral-shRNA in HASMCs significantly reduced the expression of contractile protein calponin and α-SMA ( Figure Taken together, both in vivo and in vitro evidences demonstrate that VSMC-specific GATA-6 deletion results in VSMC transformation from contractile to proliferative synthetic phenotype, promotes cell migration in vitro, and finally leads to an increase of wire injury-induced neointimal formation, therefore providing direct in vivo evidence of the inhibitory effects of VSMC-GATA-6 on injury-induced neointimal hyperplasia.
Identification of CCN-5 as a Novel Direct Target Gene of GATA-6 in VSMCs and Elevated Expression of CCN-5 Rescues the GATA-6 DeletionMediated Enhanced Neointimal Hyperplasia In Vivo
To gain insight into the underlying molecular mechanisms of VSMC-GATA-6 deletion-mediated increased neointimal hyperplasia, RNA high-throughput sequencing was performed using aortic smooth muscle from fluorescent reporter mutants GATA6 (Table II in the online-only Data Supplement), which was further confirmed by RT-qPCR and Western blot ( Figure 6A and 6B) .
To validate whether CCN-5 is a direct GATA-6 target gene, we performed chromatin immunoprecipitation assays in mouse aortic SMCs, and the results showed a direct association of GATA-6 with the mouse CCN-5 promoter ( Figure 6C ). To determine whether GATA-6 could directly activate CCN-5 transcription, we searched GATA-6-binding sites in the promoter region of CCN-5 gene from −5 kb to translational starting site and found 7 GATA-6-binding sites ( Figure XIA in the online-only Data Supplement), and 2 GATA-6-binding motif are evolutionarily conserved among mouse, opossum, and human genomes in the promoter region of −3.3 kb to −3 kb of CCN-5 gene ( Figure XIB and XIC in the online-only Data Supplement) using ECR browser (http://ecrbrowser.dcode.org) analysis. We cloned the sequence −3.3 kb to −2.3 kb containing 2 GATA-6-conserved binding sites into pGL3 basic luciferase reporter vector ( Figure 6D ; Figure XID in the online-only Data Supplement) and luciferase reporter assay showed that GATA-6 activated the luciferase activity in a dose-dependent manner ( Figure 6E ), whereas removal of the GATA-6-binding sites ( Figure XIE in the online-only Data Supplement) reversed the activated luciferase activity ( Figure 6F ). Further we cloned the sequence −3.5 kb to −0.9 kb of CCN-5 gene containing Figure 6I  and 6J) . Therefore, these results provide in vivo evidence that VSMC-GATA-6-CCN-5 pathway might regulate VSMC transformation from contractile to synthetic phenotype and proliferation, which is responsible for the GATA-6 deletion-mediated increased neointimal hyperplasia in vivo.
CCN-5 Overexpression in VSMCs Reverses the GATA-6 Knockdown-Mediated Proliferative Synthetic Phenotype Transformation and Increase of Cell Proliferation and Migration In Vitro
Consistent with these in vivo findings, shRNA knockdown of GATA-6 in HASMCs significantly decreased the CCN-5 expression by RT-qPCR and Western blot ( Figure 7A and 7B) compared with the control scramble-shRNA. A lentiviral CCN-5 overexpression vector was constructed to investigate whether SMCKO mutants compared with wild-type littermates (n=3). C, Chromatin immunoprecipitation assay shows an association of GATA-6 with mouse CCN-5 promoter by qPCR (right) and in agarose gel (left; n=3). D-F, The promoter region of CCN-5, 3.3 kb to −2.3 kb has 2 conserved GATA-6 binding sites (D) and GATA-6 expression vector dose-dependently transactivates the luciferase reporter activity of this CCN-5 promoter region in NIH-3T3 cells (E), and mutation of the GATA-6-binding motif in the promoter reverses the activated luciferase activity (F; n=3) . G and H, Elevated CCN-5 expression in VSMC-specific CCN-5 overexpression mice CCN5 SMCTg or by local delivery of lentiviral-CCN-5 to the injured vessel reverses the increased neointimal hyperplasia in GATA6 SMCKO mutant mice compared with wild-type littermates or control lentiviral vector, with representative images (G) and quantification of neointima area, intima-to-media ratio, % stenosis and media area (H; n=7 for each group). I and J, Elevated VSMC-CCN-5 expression in VSMCspecific CCN-5 overexpression mice CCN5 SMCTg or by local delivery of lentiviral-CCN-5 to the injured vessel reverses the reduction of α-SMA (alpha-smooth muscle actin; I) and increase of Ki67-positive cells (J) in neointima of GATA6 SMCKO mutant mice, with representative images (left) and quantification of neointima area, intimato-media ratio, % stenosis and media area (right; n=7 for each group). *P<0.05, **P<0.01. G, I, J, Scale bars: 100 µm. NS indicates nonsignificant.
CCN-5 is involved in GATA-6 regulation of VSMC proliferation and migration. The efficiency of CCN-5 overexpression in HASMCs was confirmed by Western blot ( Figure 7C ). CCN-5 overexpression in HASMCs reversed the GATA-6 knockdownmediated reduced expression of contractile protein calponin and α-SMA ( Figure 7C ), as well as the increase of cell proliferation ( Figure 7D through 7F) and migration ( Figure 7G and 7H) compared with the control lentiviral vector. Cell cycle analysis further confirmed the reversal effect of CCN-5 overexpression on the increased S-phase and reduced G 0/1 -phase cell numbers in GATA-6 knockdown HASMCs ( Figure 7I ). These results confirmed that GATA-6 knockdown in cultured VSMCs reduced CCN-5 expression, and CCN-5 overexpression in cultured VSMCs reversed the GATA-6 knockdown-mediated VSMC proliferative synthetic phenotype transformation and increased cell migration which might contribute to the increased injuryinduced neointimal hyperplasia in vivo.
Taken together, these data indicate that GATA-6 regulates CCN-5 in a cell-autonomous manner to maintain VSMC contractile phenotype and inhibit VSMC proliferation and migration, therefore protecting from injury-induced neointimal hyperplasia. In contrast, the GATA-6 in ECs activates PDGF-B and promotes VSMC proliferation and migration in a paracrine manner and eventually enhances the artery ligation-and injury-induced neointimal hyperplasia ( Figure XV in the online-only Data Supplement).
Discussion
Vascular injury-provoked proliferation of medial VSMCs and migration to the subendothelial space are believed to contribute to restenosis that occurs after balloon angioplasty and PCI. An early study demonstrated that GATA-6 downregulation is an essential feature of injured vessel and adenoviral delivery of GATA-6 to the injured vessel reversed the restenotic vascular neointimal hyperplasia. 9 However, no study has identified which type of vascular cells was involved in GATA-6 responses in neointimal formation in vivo. Here, we show that GATA-6 controls this process by increasing expression of PDGF-B in ECs, thereby promoting VSMC proliferation and migration in a cell-nonautonomous fashion during injury-induced neointimal formation, whereas in VSMCs GATA-6 increases expression of CCN-5, which in turn inhibits VSMC synthetic phenotype transformation, VSMC proliferation and migration in a cellautonomous fashion. These studies highlight the importance of maintaining the correct balance of signals that allow for maintenance of VSMC homeostasis for regulation of injury-induced neointimal hyperplasia and demonstrate that GATA-6 plays a critical role in neointimal formation via a cell-specific manner.
Unlike terminally differentiated skeletal and cardiac muscle cells, VSMCs retain the ability to modulate phenotypes ranging from the contractile state to the proliferative synthetic state in response to physiological and pathological stimuli. On vascular injury, VSMCs alter their phenotype towards a dedifferentiated state characterized by decreased expression of SMC marker genes, including SMA, SM-MHC, and calponin, and displays an increased cell proliferation and migration. 7, 9 This plasticity of VSMCs is important in the pathogenesis of vasculoproliferative syndromes, including restenosis and atherosclerosis.
GATA-6 is highly expressed in quiescent VSMCs and contributes to the maintenance of the contractile phenotype of VSMCs. 7, 8, 32, 33 This study showed that GATA-6 deletion in VSMCs enhanced injury-induced neointimal formation. RNAsequencing bioinformatic analysis indicated 158 upregulated genes and 665 downregulated genes in aortic SMCs of GATA-6 deletion mice compared with the wild-type control littermate mice. Differential genes between wild-type and GATA6 SMCKO mice were enriched for cellular process, metabolic process, cell part organelle binding, etc (Table II in the online-only Data Supplement), and the top list gene downregulated is CCN-5. Reduced CCN-5 expression on loss of GATA-6 in VSMCs in vivo led to increased VSMC transformation to synthetic phenotype, and enhanced VSMC proliferation and migration, which implies an important role of this factor in injury-induced neointimal formation. Previous study has implicated CCN-5 was associated with VSMC contractile phenotype as it was highly expressed in the medial portion of vessel in which VSMCs were quiescent, but the sharply reduced expression of CCN-5 was observed in the media after balloon injury of rat carotid artery, and CCN-5 could inhibit cultured VSMC proliferation, motility, and invasiveness. 34, 35 However, it was still unknown whether the regulation of CCN-5 expression by GATA-6 in VSMCs would influence the VSMC synthetic phenotype transformation in vivo and further alter VSMC proliferation and migration, and finally control neointimal formation. Our data suggest that loss of GATA-6 in VSMCs leads to the reduced CCN-5 expression because of lack of insufficient transcription activation of the latter, and this, in turn, leads to an increase in neointimal formation, which could be rescued by VSMC-specific CCN-5 overexpression in CCN5 SMCTg mice or local delivery of lentiviral CCN-5 to the injured artery, therefore providing an in vivo evidence of VSMC-GATA-6 regulation of CCN-5 controlling injury-induced neointimal hyperplasia.
In addition to CCN-5, RNA-sequencing in this study showed that endothelin-1, as well as endothelin-converting enzyme 1, and cyclin-dependent kinase inhibitor 1C (P57) and 2C (P18) were downregulated in VSMC-GATA-6 deletion mice as our previous study reported. 5, 36 Sequence analysis found GATA-6-binding sites in the promoter region of these genes (data not shown) indicating possible direct target genes of GATA-6, suggesting that VSMC-GATA-6 might regulate many genes responsible for SMC phenotypic change and control neointimal formation during vascular injury.
Coronary artery interventions using device implants reduce the risk of restenosis and the need for further revascularization but are associated with endothelial denudation and impaired function, which are major factors to promote VSMC proliferation and migration to the subendothelial space forming neointimal hyperplasia, ultimately leading to restenosis and intervention failure. 37 ECs are crucial in maintaining vascular health, and GATA-6 deletion in ECs decreased the neointimal hyperplasia following wire injury, which provides us that GATA-6 plays a role in maintaining the function of ECs. However, GATA-6 deficient in ECs reduces vascular recovery and EC proliferation and migration ( Figure IV in the online-only Data Supplement). So, we performed RNA-sequencing to seek potential paracrine factors under control of GATA-6 contributing to the EC-GATA-6-mediated decreased neointimal formation. Our RNA-sequencing results showed 81 upregulated genes and 181 downregulated genes in ECs of GATA-6 deletion mice compared with the wild-type control littermate mice. The EC-GATA-6-regulated genes mostly are downregulated in immune process, inflammatory response, stress response, and metabolic process, etc and upregulated in signal transduction and cell death pathways, etc (Table I in the online-only Data Supplement).
PDGF-B was originally purified from platelets, and generally released from aggregating platelets at sites of endothelial injury, which plays a key role in the migration of VSMC from the media into the intima, as well as in the subsequent proliferation of the VSMCs at this site. 38 Normal vessels generally express low or undetectable levels of PDGF-B, however, PDGF-B expression can be induced in all cells that comprise the normal artery wall and in inflammatory cells that infiltrate the artery in response to pathological stimuli. 39 An early study showed that increased PDGF expression 4-fold by in situ hybridization in a vessel with reduced flow as compared with increased flow in vivo. 40 A more recent study showed that low shear stress modulated PDGF-B expression in ECs and induced proliferation and migration of VSMCs, providing a paracrine control by PDGF-B on low shear stress-induced VSMC proliferation and migration. 30 Our study demonstrated that PDGF-B was a GATA-6 direct target gene in ECs and loss of EC GATA-6 led to reduction of PDGF-B expression in ECs, which inhibited VSMC proliferation and migration and in turn attenuated injury-induced neointimal hyperplasia. Therefore, this study provided the direct in vivo evidence of GATA-6 regulation of EC-PDGF-B on VSMC proliferation and migration and further on artery ligation or injury-induced neointimal formation.
RNA-sequencing analysis of EC-GATA-6 deletion and wild-type mice demonstrated many possible GATA-6 regulated genes involved in inflammation, such as carbonyl reductase-2, chemokine (C-C motif) receptor-2, IL (interleukin)-18, chemokine (C-C motif) ligand-5, interferon-γ-induced GTPase, etc in ECs, and GATA-6-binding sites were observed in the promoter region of these genes (data not shown), indicating that EC-GATA-6 might influence many inflammatory response genes, together with PDGF-B, to regulate the VSMC phenotypic change and further control the neointimal formation during vascular injury.
GATA-6 normally acts as a transcriptional activator, but it represses cyclin A expression by interaction with a family of transcriptional repressors called "Friends" of GATA. 5 In this study, we found CCN-5 downregulated in VSMCs, but upregulated in ECs in GATA-6 cell-specific deletion mice (data not shown). Therefore, future study of the cell-specific regulation of GATA-6 on gene expression via its interacting repressor proteins and the epigenetic inhibiting or activating genes expression by modifying the chromatin status will clarify the mechanisms that GATA-6 cell-specifically regulates different genes and controls the neointimal formation during injury.
Further study showed that mouse VSMCs had low PDGF-B expression level and was not influenced by GATA-6 deletion (data not shown), suggesting that CCN-5, not PDGF-B, might regulate VSMC phenotypic changes contributing to the aggravated neointimal formation during injury in SMC GATA-6 deletion mice. Reversal of both in vivo and in vitro phenotypic changes of GATA-6 deletion by elevated VSMC-CCN-5 further supported that the reduced expression of CCN-5 might be responsible for the enhanced injury-induced neointima formation caused by loss of GATA-6 in VSMCs. While EC-GATA-6 deletion downregulated PDGF-B expression, but elevated CCN-5 expression, and this is opposite to the VSMC-GATA-6 deletion mice (data not shown). Therefore, future study of GATA-6-interacting repressor proteins will clarify the mechanisms of cell-specific GATA-6 regulatory genes in neointimal formation.
Given the need for a better understanding of how to regulate the transformation of VSMC contractile phenotype to synthetic phenotype and further proliferation and migration to limit the occurrence of restenosis after PCI, the present study shows that loss of GATA-6 in different cell lineages within the vessels results in different VSMC responses after injury, exemplifying that the expression of a single transcription factor in different cell lineages is critical to balance the cell-autonomous and noncell-autonomous regulation of injury-induced VSMC responses. This study provides a direct in vivo evidence of GATA-6 cell lineage-specific regulation of PDGF-B and CCN-5 on VSMC phenotypic state, proliferation, and migration that contributes to neointimal formation, which provides opportunities for future cell type-specific drug target for better therapeutic intervention of post-PCI restenosis and cardiovascular diseases.
